Metrorrhagia

27 registered clinical trials studyying Metrorrhagia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes NCT06802198	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Recruiting	Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users NCT07083635	Chulalongkorn University	Phase 2
Withdrawn	Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) NCT05538689	University of Chicago	Phase 4
Completed	Therapeutic Effect of Herbal Infusion on Menometrorrhagia NCT05406960	Faculty of Medicine, Sousse	N/A
Completed	Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation NCT03121560	Brugmann University Hospital	N/A
Unknown	Cooperative Adenomyosis Network NCT03230994	Peking Union Medical College Hospital	—
Completed	Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG NCT02824224	Oregon Health and Science University	Phase 4
Completed	Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test. NCT03250884	Rennes University Hospital	—
Completed	Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users NCT02311478	University of Utah	N/A
Withdrawn	Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol NCT01557023	Eurofarma Laboratorios S.A.	Phase 3
Completed	Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs NCT01918072	VA Office of Research and Development	—
Completed	Surgical Success After Laparoscopic vs Abdominal Hysterectomy NCT01793584	University of Texas Southwestern Medical Center	N/A
Completed	Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding NCT01638923	Bayer	Phase 3
Completed	Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Unde NCT01647360	Abbott	—
Completed	A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postm NCT01436513	Pfizer	Phase 1
Completed	Minimally Invasive Benign Hysterectomy NCT01865929	Region Skane	N/A
Completed	Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation NCT00563576	Columbia University	N/A
Completed	Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding NCT00307801	Bayer	Phase 3
Completed	Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding NCT00293059	Bayer	Phase 3
Completed	Study of Asoprisnil in the Treatment of Uterine Fibroids. NCT00156156	Abbott	Phase 3
Completed	Safety of Treatment of Uterine Fibroids With Asoprisnil NCT00156208	Abbott	Phase 3
Completed	An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets NCT00344383	McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.	Phase 2
Completed	A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids NCT00152256	Abbott	Phase 3
Completed	Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids NCT00156195	Abbott	Phase 3
Completed	A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids NCT00160381	Abbott	Phase 3
Completed	Treatment of Uterine Fibroids With Asoprisnil(J867) NCT00152269	Abbott	Phase 3
Completed	An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen NCT00320580	McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.	Phase 2